Shifting Paradigms in Cardiovascular Therapeutic Strategies During the COVID-19 Era

Ran Kornowski1

  • 1Department of Cardiology, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel.

Insights

During the COVID-19 pandemic, cardiac interventions shifted to less invasive methods to shorten hospital stays. This strategy was applied to both coronary and structural/valvular heart conditions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • The COVID-19 pandemic necessitated significant adaptations in healthcare delivery.
  • Cardiac interventions faced challenges due to resource limitations and infection control concerns.

Purpose of the Study:

  • To describe a modified approach to cardiac interventions during the COVID-19 pandemic.
  • To evaluate the prioritization of minimally invasive procedures and reduced hospitalization.

Main Methods:

  • Implementation of a new protocol for cardiac interventions, emphasizing less invasive techniques.
  • Focus on reducing length of hospital stay for both coronary and structural/valvular cases.
  • Retrospective review of cases managed under the modified approach.

Main Results:

  • Prioritization of emergent cardiac care with a focus on minimally invasive options.
  • Successful reduction in hospitalization duration for cardiac intervention patients.
  • Application of this strategy across both coronary and structural/valvular heart disease categories.

Conclusions:

  • The adapted approach to cardiac interventions during COVID-19 prioritized patient safety and resource management.
  • Minimally invasive strategies and shorter hospital stays are deemed appropriate for this unique period.
  • Further research is required to validate this approach in diverse international settings.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
130
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
339
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
185
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
266
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
157
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K